A bill commonly known as “Right to Try,” or S.204, appears to be a step in the right direction for expanding access to treatment for terminally ill patients who have exhausted all other options.
Health Policy Urology
"Although we commend the USPSTF for upgrading the recommendation for PSA- and digital rectal exam-based prostate cancer screening from a “D” to a “C” grade (JAMA 2018; 319:1901–13), we believe that not enough emphasis is placed on screening high-risk groups for prostate cancer," write Navin Shah, MD, and Vladimir Ioffe, MD.
The final recommendation on screening for prostate cancer issued May 8 by the U.S. Preventive Services Task Force, which gives a “C” grade for PSA testing in men 55-70 years of age, has been met with mixed reviews by prostate cancer-focused organizations, some of which continue to call for legislation to reform the task force itself.
"The topic of overlapping surgery remains a misunderstood and controversial issue," writes the AACU's Ross E. Weber.
Independence isn’t gone entirely in today’s urology practice environment, but it is different.
Forty-nine physician organizations across the medical spectrum, including urology, have urged CMS to reduce the period for reporting quality measures from a full year to a minimum of 90 days for 2018 under the Merit-based Incentive Payment System.
"No matter the most accurate interpretation of the current spate of retirements, the volume of vacancies promises to alter the political calculus in Washington," writes the AACU's Brian Henderson.
"Aetna and UnitedHealth’s decision to pass through rebates to patients is laudable, but it does not address key concerns with [pharmacy benefit manager] practices that drive up the cost of prescription drugs," writes the AACU's Brian Henderson.
"Vertical integrations are creating behemoths that limit competition within the health care space, thereby limiting options and opportunities for patients, physicians, and medical practices," according to Ally Lopshire, JD, of the AACU.
In this interview, Michael Palese, MD, discusses subspecialization, its benefits for clinicians and patients, and what the future “office urologist” may look like.